Skip to main content

Table 2 Clinicopathological variables of GC patients

From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis

Characteristic

Status

Number of patients (%)

Blood Group

A + 

9 (18%)

B + 

7 (14%)

B-

11 (22%)

O + 

5 (10%)

O-

3 (6%)

AB

12 (24%)

Unknown

4 (8%)

Smoking

Yes

14 (28%)

No

36 (72%)

Unknown

0

H. Pylori

Positive

12 (24%)

Negative

21 (42%)

Unknown

17 (34%)

Tumor Stage

I

12 (24%)

II

11 (22%)

III

8 (16%)

IV

13 (26%)

Unknown

6 (12%)

Metastasis

Positive

19 (38%)

Negative

21 (42%)

Unknown

10 (20%)

Tumor Size

 > 6 cm

17 (34%)

 < 6 cm

31 (62%)

Unknown

2 (4%)

Tumor location

Greater curvature

17 (34%)

Lesser curvature

12 (24%)

Cardia

10 (20%)

Antrum

11 (22%)

Unknown

0

Histological type

Mucinous adenocarcinoma

11 (22%)

Intestinal

12 (24%)

Signet ring cell

16 (32%)

Unknown

6 (12%)